Parkinson's disease or Parkinson symptoms following seasonal influenza

Influenza and other Respiratory Viruses

Volumn 5, Issue 5, 2011, Pages 328-333

  Toovey, Stephen ^a   Jick, Susan S ^b   Meier, Christoph R ^b,c,d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Case control studies; Influenza; Parkinson's disease; Parkinsonism

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GAIT DISORDER; GENERAL PRACTICE; HUMAN; IDIOPATHIC DISEASE; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL INFLUENZA; SEASONAL VARIATION; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; RISK FACTORS; SEASONS;

EID: 80051571830     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00232.x     Document Type: Article

References (30)

1. Van DenEeden SK, Tanner CM, Bernstein AL et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157:1015-1022.
2. Findley LJ. The economic impact of Parkinson's disease. Parkinsonism Relat Disord 2007; 13(Suppl):S8-S12.
3. Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19:834-842.
4. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008; 6:114-124.
5. Toovey S, Rayner C, Prinssen E et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008; 31:1097-1114.
6. Smith JR, Sacks S. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract 2009; 63:596-605.
7. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. Validity of the general practice research database. Pharmacotherapy 2003; 23:686-689.
8. Becker C, Jick SS, Meier CR. Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK. Drug Saf 2008; 31:399-407.
9. Alonso A, Rodriguez LA, Logroscino G, Hernan MA. Gout and risk of Parkinson disease: a prospective study. Neurology 2007; 69:1696-1700.
10. Becker C, Brobert GP, Johansson S, Jick SS, Meier CR. Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care 2008; 31:1808-1812.
11. Becker C, Jick SS, Meier CR. Use of antihypertensives and the risk of Parkinson disease. Neurology 2008; 70:1438-1444.
12. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002; 52:276-284.
13. Hernan MA, Logroscino G, Rodriguez LA. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol 2004; 251(Suppl 7):vII14-vII17.
14. Hernan MA, Logroscino G, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology 2006; 66:1097-1099.
15. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356:29-38.
16. Elbaz A, Moisan F. Update in the epidemiology of Parkinson's disease. Curr Opin Neurol 2008; 21:454-460.
17. Postuma RB, Wolfson C, Rajput A et al. Is there seasonal variation in risk of Parkinson's disease? Mov Disord 2007; 22:1097-1101.
18. Ghaemi M, Rudolf J, Schmulling S, Bamborschke S, Heiss WD. FDG- and Dopa-PET in postencephalitic parkinsonism. J Neural Transm 2000; 107:1289-1295.
19. Maurizi CP. Postencephalitic Parkinson's disease, amyotrophic lateral sclerosis on Guam and influenza revisited: focusing on neurofibrillary tangles and the trail of tau. Med Hypotheses 2002; 58:198-202.
20. Takahashi M, Yamada T. Viral etiology for Parkinson's disease--a possible role of influenza A virus infection. Jpn J Infect Dis 1999; 52:89-98.
21. Ravenholt RT, Foege WH. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 1982; 2:860-864.
22. Mortimer PP. Was encephalitis lethargica a post-influenzal or some other phenomenon? Time to re-examine the problem Epidemiol Infect 2009; 137:449-455.
23. Special article. Epidemic or lethargic encephalitis (nona). JAMA 1919; 72:794-795.
24. Hall AJ. Epidemic Encephalitis (encephalitis lethargica). Bristol: Wright, 1924.
25. Lo KC, Geddes JF, Daniels RS, Oxford JS. Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920. Virchows Arch 2003; 442:591-596.
26. Hosoya M, Nunoi H, Aoyama M, Kawasaki Y, Suzuki H. Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J 2005; 24:467-470.
27. Kido H, Yao D, Le TQ, Tsukane M, Chida J. Analysis of SNPs and enzymatic disorder in the patients of influenza-associated encephalopathy: disorder of fatty acid metabolism in mitochondria induced by high fever. Nippon Rinsho 2006; 64:1879-1886.
28. Yamanaka G, Kawashima H, Suganami Y et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci 2006; 243:71-75.
29. Maricich SM, Neul JL, Lotze TE et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics 2004; 114:e626-e633.
30. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta 2009; 1792:714-721.